Literature DB >> 24140748

Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.

Feng Jia1, Xunpei Liu, Linheng Li, Surya Mallapragada, Balaji Narasimhan, Qun Wang.   

Abstract

Nanoparticles (NPs) have been extensively investigated for applications in both experimental and clinical settings to improve delivery efficiency of therapeutic and diagnostic agents. Most recently, novel multifunctional nanoparticles have attracted much attention because of their ability to carry diverse functionalities to achieve effective synergistic therapeutic treatments. Multifunctional NPs have been designed to co-deliver multiple components, target the delivery of drugs by surface functionalization, and realize therapy and diagnosis simultaneously. In this review, various materials of diverse chemistries for fabricating multifunctional NPs with distinctive architectures are discussed and compared. Recent progress involving multifunctional NPs for immune activation, anticancer drug delivery, and synergistic theranostics is the focus of this review. Overall, this comprehensive review demonstrates that multifunctional NPs have distinctive properties that make them highly suitable for targeted therapeutic delivery in these areas.
© 2013.

Entities:  

Keywords:  Anticancer drug delivery; Immune activation; Multifunctional; Nanoparticles; Theranostics

Mesh:

Substances:

Year:  2013        PMID: 24140748     DOI: 10.1016/j.jconrel.2013.10.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

Review 1.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

Review 2.  Capacity of gold nanoparticles in cancer radiotherapy.

Authors:  Nadeem M S Nagi; Yasir A M Khair; Ahmed M E Abdalla
Journal:  Jpn J Radiol       Date:  2017-08-09       Impact factor: 2.374

3.  Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.

Authors:  Didier Dréau; Laura Jeffords Moore; Merlis P Alvarez-Berrios; Mubin Tarannum; Pinku Mukherjee; Juan L Vivero-Escoto
Journal:  J Biomed Nanotechnol       Date:  2016-12       Impact factor: 4.099

Review 4.  Nanoformulations for combination or cascade anticancer therapy.

Authors:  Lei Miao; Shutao Guo; C Michael Lin; Qi Liu; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

Review 5.  Potential applications of nanoparticles in cancer immunotherapy.

Authors:  Yimei Jia; Abdelwahab Omri; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2016-11-21       Impact factor: 3.452

6.  Direct Loading of iTEP-Delivered CTL Epitope onto MHC Class I Complexes on the Dendritic Cell Surface.

Authors:  Shuyun Dong; Peng Wang; Peng Zhao; Mingnan Chen
Journal:  Mol Pharm       Date:  2017-08-28       Impact factor: 4.939

Review 7.  Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.

Authors:  Mirza Ali Mofazzal Jahromi; Parham Sahandi Zangabad; Seyed Masoud Moosavi Basri; Keyvan Sahandi Zangabad; Ameneh Ghamarypour; Amir R Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2017-08-04       Impact factor: 15.470

8.  Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway.

Authors:  Priya Muralidharan; Don Hayes; Stephen M Black; Heidi M Mansour
Journal:  Mol Syst Des Eng       Date:  2016-01-27

9.  Polymer directed self-assembly of pH-responsive antioxidant nanoparticles.

Authors:  Christina Tang; Devang Amin; Phillip B Messersmith; John E Anthony; Robert K Prud'homme
Journal:  Langmuir       Date:  2015-03-20       Impact factor: 3.882

Review 10.  Modulation of Immune Response Using Engineered Nanoparticle Surfaces.

Authors:  Daniel F Moyano; Yuanchang Liu; Dan Peer; Vincent M Rotello
Journal:  Small       Date:  2015-11-30       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.